Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard Aldrich currently holds 358,500 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Aldrich has been a net buyer of PTCT stock. They have purchased $38.3M and sold $3.3M worth of shares.
Richard Aldrich's most recent insider trade was on Mar 6, 2023, when they sold 342,100 shares at $0.00 per share.
Richard Aldrich serves as Executive at PTC THERAPEUTICS, INC. (PTCT). They have executed 292 insider transactions totaling $41.6M over their tenure at the company.
Richard Aldrich holds the position of Executive at PTC THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Richard Aldrich has shown a buying trading pattern, with $38.3M in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Richard Aldrich was on Oct 12, 2017, when they purchased $4.9M worth of KALV shares. This transaction involved 565,065 shares at $8.61 per share.
Richard Aldrich currently owns 358,500 shares of PTC THERAPEUTICS, INC. (PTCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard Aldrich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard Aldrich has 292 Form 4 filings on record as an insider at PTC THERAPEUTICS, INC..
Set alerts for Richard Aldrich and 40,000+ other insiders.